Sanofi Consumer Healthcare India Stock Sinks to New 52-Week Low at Rs 3,903: Key Reasons Behind the Decline
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
SANOFICONR Share Price moved to Rs 3,912.95, down 1.02% from the previous close, after the stock touched a fresh 52-week low of Rs 3,903. Sanofi Consumer Healthcare India Ltd. now has a market capitalisation of Rs 9,104.35 crore. The price event is important because the supplied market data confirms a new yearly low, while the available figures do not establish a company-specific catalyst. For readers tracking SANOFICONR Share Price Today, the latest snapshot also places the move in the context of a comparatively premium valuation within the healthcare set. Univest records the event as a fresh one-year low and updates the SANOFICONR Share Price page for stock news, analysis and market context.
SANOFICONR Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,912.95 |
| Previous Close | Rs 3,953.15 |
| Today's Move | Rs -40.2 (-1.02%) |
| Open | Rs 3,925 |
| High | Rs 4,029.95 |
| Low | Rs 3,903 |
| Turnover | Rs 0.02 crore |
| Market Capitalisation | Rs 9,104.35 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) traded at Rs 3,912.95. versus the previous close of Rs 3,953.15, a fall of 1.02%. The stock opened at Rs 3,925, reached Rs 4,029.95, touched Rs 3,903.
SANOFICONR Share Price opened at Rs 3,925 and moved between Rs 4,029.95 and Rs 3,903 during the session. The stock ended at Rs 3,912.95 versus the previous close of Rs 3,953.15, which is a decline of Rs 40.20 or 1.02%. The day’s low matched the 52-week low, confirming a fresh yearly low in the latest SANOFICONR Stock News update. Turnover stood at Rs 0.02 crore, and market capitalisation was Rs 9,104.35 crore. In simple terms, the day’s range shows the market tested a new low without any supplied data explaining the trigger. That makes SANOFICONR Share Price Today a factual stock news event rather than a story with a verified catalyst. The next step in SANOFICONR Share Price analysis is to place this move against financial valuation and sector benchmarks.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,104.35 crore |
| P/E Ratio | 34.23x |
| P/B Ratio | 26.17x |
| ROE | 73.2% |
| ROCE | 98.11% |
| EPS | Rs 115.5 |
| Book Value Per Share | Rs 151.07 |
| Dividend Yield | 1.9% |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamental metrics show P/E 34.23x, P/B 26.17x, ROE 73.2%, ROCE 98.11%. These figures provide context only and are not a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 9104.35 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.23x, P/B at 26.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 73.2% and ROCE of 98.11%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 115.5, book value per share of Rs 151.07, dividend yield of 1.9%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.67x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 34.23x |
| Benchmark Median P/E | 32.67x |
| Benchmark Average P/E | 49.72x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 26.17x |
| Benchmark Median P/B | 2.84x |
| Company ROE | 73.2% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 98.11% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 9,104.35 crore |
| Benchmark Median Market Cap | Rs 722.23 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 34.23x, which is above the benchmark median of 32.67x, a difference of +4.78%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROE of 73.2%, which is above the benchmark median of 11.43%, a difference of +540.42%. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROCE of 98.11%, which is above the benchmark median of 13.1%, a difference of +648.93%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Procter & Gamble Health Ltd. | PGHL | 8,987.15 | 25.18 | 14.6 | 62.18 | 84.86 |
| Aarti Pharmalabs Ltd. | AARTIPHARM | 8,514.38 | 39.95 | 3.89 | 8.5 | 10.77 |
| Supriya Lifescience Ltd. | SUPRIYA | 7,926.35 | 39.96 | 6.49 | 19.06 | 25.3 |
| Sequent Scientific Ltd. | VIYASH | 10,795.59 | 63.07 | 3.84 | 9.06 | 13.1 |
| Blue Jet Healthcare Ltd. | BLUEJET | 10,798.18 | 45.97 | 4.82 | 19.88 | 27.18 |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 34.23x compared with the displayed peer median of 39.96x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 73.2% compares with a peer median of 19.06% across the companies shown in the table. ROCE stood at 98.11% versus the displayed peer median of 25.3%, providing a capital-efficiency comparison. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a market capitalisation of Rs 9,104.35 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching SANOFICONR
- SANOFICONR Share Price hit a fresh 52-week low at Rs 3,903 during the session.
- The stock closed at Rs 3,912.95, down Rs 40.20 or 1.02% from the previous close.
- Market capitalisation stands at Rs 9,104.35 crore, keeping SANOFICONR Share Price in a clearly defined size bracket.
- P/E is 34.23 and P/B is 26.17, which remain above the industry median values in the supplied benchmark.
- ROE is 73.2% and ROCE is 98.11%, both materially above the sector medians shown in the data.
About SANOFICONR
Sanofi Consumer Healthcare India Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its NSE symbol SANOFICONR and places it in the same-industry benchmark set used for the sector snapshot and peer comparison. SANOFICONR Share Price readers are therefore looking at a listed healthcare company whose latest stock move can be assessed alongside valuation, profitability and sector context from the verified dataset.
Track SANOFICONR Share Price on Univest
Use Sanofi Consumer Healthcare India Ltd. (SANOFICONR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Univest tracks SANOFICONR Share Price with live market snapshots, valuation ratios, 52-week levels, sector context, shareholding pattern data and linked stock research. For readers following SANOFICONR Share Price Today, Univest keeps the latest market update in one place and makes it easier to review SANOFICONR Stock News alongside benchmark comparisons.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did SANOFICONR Share Price hit a fresh 52-week low?
Ans. The supplied market data confirms a fresh 52-week low at Rs 3,903, but it does not establish a company-specific catalyst. The session closed at Rs 3,912.95 after a 1.02% decline.
What is SANOFICONR Share Price today?
Ans. SANOFICONR Share Price today is Rs 3,912.95. It moved down Rs 40.20, or 1.02%, from the previous close of Rs 3,953.15 after touching Rs 3,903. The stock moved -1.02% during the session.
What is the 52-week low for SANOFICONR?
Ans. The fresh 52-week low for SANOFICONR is Rs 3,903. The day’s low matched that level, so the stock is now flagged as a yearly low in the latest update. The stock moved -1.02% during the session.
What is the market capitalisation of Sanofi Consumer Healthcare India Ltd.?
Ans. Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 9,104.35 crore. That figure places SANOFICONR Share Price within the supplied healthcare benchmark set for comparison. The company operates in the Healthcare sector.
How do SANOFICONR valuation ratios compare with sector data?
Ans. SANOFICONR Share Price has a P/E of 34.23 and a P/B of 26.17. Against the sector medians of 32.67 and 2.84, both measures are higher in the supplied snapshot. The company trades at a P/E ratio of 34.23x.
What do ROE and ROCE show for SANOFICONR?
Ans. SANOFICONR reports ROE of 73.2% and ROCE of 98.11%. Both are far above the healthcare benchmark medians, giving SANOFICONR Share Price a strong profitability backdrop in the data. ROE stands at 73.2%.
What is the EPS and book value for SANOFICONR Share Price?
Ans. EPS is Rs 115.5 and book value is Rs 151.07. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share in SANOFICONR Share Price.
What dividend yield is shown for SANOFICONR?
Ans. The supplied dividend yield for SANOFICONR is 1.9%. It is a historical or current payout measure, so readers use it as part of SANOFICONR Share Price analysis rather than as a guarantee.
How does SANOFICONR compare with listed peers?
Ans. SANOFICONR Share Price has a higher P/E than Procter & Gamble Health Ltd. and Sanofi India Ltd., but lower than Sequent Scientific Ltd. and Blue Jet Healthcare Ltd. Its ROE and ROCE are the highest in the supplied peer set.
Is SANOFICONR Share Price relevant for stock news tracking?
Ans. Yes. SANOFICONR Share Price is relevant for stock news tracking because it has reached a fresh 52-week low, while the latest valuation and peer data provide a fuller factual view of the event.
